ArticleJournal of thoracic disease2025
Quality of life and survival of achieving textbook outcome for resectable esophageal squamous cell carcinoma.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The relationship between textbook outcome (TO) and health-related quality of life (QOL) is unclear. Our purpose is to investigate the relationship between achieving TO and survival and postoperative QOL in individuals with esophageal squamous cell carcinoma (ESCC). Methods: We conducted analyses of consecutive patients with ESCC who underwent minimally invasive McKeown esophagectomy in a single center from April 2019 to December 2020. The patients were grouped into a TO group and a non-TO group. The longitudinal QOL was handled using a linear mixed effect model. The European Organization for Research and Treatment of Cancer (EORTC) questionnaires were used to assess symptoms and QOL. Results: One hundred and twenty-three patients (33.3%) achieved TO. Postoperative complications and insufficient lymph node dissection were the main reasons that hindered achieving TO. In the EORTC Quality of Life Questionnaire Core-30 (EORTC QLQ-C30) and EORTC Quality of Life Esophagus-specific Questionnaire (EORTC QLQ-S18) scales, compared to the non-TO group, the TO group reported worse social function, more financial impact, less trouble with taste, milder dysphagia and better disease-free survival (DFS) and overall survival (OS). Conclusions: Patients who could achieve the TO might experience a milder dysphagia symptom, better DFS and OS in the short term after esophagectomy. The postoperative management of the patients who can achieve the TO should be strengthened to improve the postoperative QOL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.